MedPlus Q2 net profit rises 43.4% as revenue increases 6.5%
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.9 pts more than Nifty Microcap 250 and 7.2 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved unaudited results for the quarter and half year ended September 30, 2025. Consolidated quarterly revenue was Rs 16,793.29 million, up 6.5 percent. Net profit rose 43.4 percent to Rs 555.02 million. Half-year revenue rose 5.1 percent to Rs 32,219.63 million, while profit rose 84.4 percent to Rs 978.45 million. Operating cash flow was Rs 3,133.37 million.
Strong profit and cash flow growth support shareholder sentiment, but modest sales growth and Rs 11.93 billion in lease liabilities need attention.